Cost‐effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as the first‐line treatment for advanced esophageal cancer oleh Zhuo‐Miao Ye, Zhe Xu, Hao‐Lun Wang, Ying‐Yuan Wang, Ze‐Chang Chen, Qin Zhou, Xiang‐Ping Li, Ying‐Ying Zhang